WYNN
46
-4
RIG
37
2
KLAC
63
-5
MUR
48
4
USB
51
-2
CMG
50
-13
PCAR
48
2
AN
57
5
CVX
40
8
WDC
59
-2
WM
68
-2
MRO
42
-5
XRX
55
3
XYL
54
-2
HAL
50
4
ZBH
53
-3
EA
52
3
NWL
57
3
PYPL
58
2
AON
56
4
WYNN
46
-4
RIG
37
2
KLAC
63
-5
MUR
48
4
USB
51
-2
CMG
50
-13
PCAR
48
2
AN
57
5
CVX
40
8
WDC
59
-2
WM
68
-2
MRO
42
-5
XRX
55
3
XYL
54
-2
HAL
50
4
ZBH
53
-3
EA
52
3
NWL
57
3
PYPL
58
2
AON
56
4
Financhill
Back

Macrogenics Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
37

MGNX
Macrogenics

Last Price:
3.20
Seasonality Move:
19.2%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
37
Macrogenics (MGNX) is a Sell

Is Macrogenics a Buy, Sell or Hold?

  • The current Macrogenics [MGNX] share price is $3.19. The Score for MGNX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • MGNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MGNX Stock Price Chart

What is Macrogenics's stock price today?

  • The Macrogenics share price today is $3.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MGNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

MGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 42.69 Sell
Chaikin Money Flow: 542178 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.18 - 3.56) Sell
Bollinger Bands (100): (2.42 - 6.42) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

MGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.16 Buy
20-day SMA: 3.34 Sell
50-day SMA: 3.73 Sell
200-day SMA: 9.53 Sell
8-day EMA: 3.17 Buy
20-day EMA: 3.32 Sell
50-day EMA: 3.86 Sell
200-day EMA: 6.97 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Macrogenics Earnings Growth & MGNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.95 per share, a decrease next quarter of $1.10 per share, a decrease this year of $2.17 per share, and a decrease next year of $0.36 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Macrogenics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):